Serial Number | 97473191 |
Word Mark | PERIBAN |
Filing Date | Thursday, June 23, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, July 27, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Nutraceuticals for the treatment of conditions in gastrointestinal and liver health in human beings and animals; Nutritional supplements in the form of tablets, capsules, and granules from natural plants for treatment of conditions in gastrointestinal and liver health in human beings and animals |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, July 12, 2022 |
Primary Code | 005 |
First Use Anywhere Date | Thursday, June 6, 1996 |
First Use In Commerce Date | Saturday, October 11, 2014 |
Party Name | Bioved Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Jose, CA 95131 |
Event Date | Event Description |
Thursday, July 27, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Thursday, July 27, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Thursday, July 27, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, April 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, April 12, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, April 12, 2023 | NON-FINAL ACTION WRITTEN |
Tuesday, April 4, 2023 | ASSIGNED TO EXAMINER |
Tuesday, July 12, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, June 27, 2022 | NEW APPLICATION ENTERED |